These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 27261671)

  • 21. The requirement for SNF5/INI1 in adipocyte differentiation highlights new features of malignant rhabdoid tumors.
    Caramel J; Medjkane S; Quignon F; Delattre O
    Oncogene; 2008 Mar; 27(14):2035-44. PubMed ID: 17922027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A masked NES in INI1/hSNF5 mediates hCRM1-dependent nuclear export: implications for tumorigenesis.
    Craig E; Zhang ZK; Davies KP; Kalpana GV
    EMBO J; 2002 Jan; 21(1-2):31-42. PubMed ID: 11782423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural Insights into BAF47 and BAF155 Complex Formation.
    Yan L; Xie S; Du Y; Qian C
    J Mol Biol; 2017 Jun; 429(11):1650-1660. PubMed ID: 28438634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequent deletion of hSNF5/INI1, a component of the SWI/SNF complex, in chronic myeloid leukemia.
    Grand F; Kulkarni S; Chase A; Goldman JM; Gordon M; Cross NC
    Cancer Res; 1999 Aug; 59(16):3870-4. PubMed ID: 10463572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A key role of the hSNF5/INI1 tumour suppressor in the control of the G1-S transition of the cell cycle.
    Versteege I; Medjkane S; Rouillard D; Delattre O
    Oncogene; 2002 Sep; 21(42):6403-12. PubMed ID: 12226744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of early steps of HIV-1 replication by SNF5/Ini1.
    Maroun M; Delelis O; Coadou G; Bader T; Ségéral E; Mbemba G; Petit C; Sonigo P; Rain JC; Mouscadet JF; Benarous R; Emiliani S
    J Biol Chem; 2006 Aug; 281(32):22736-43. PubMed ID: 16772295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative molecular genetic analysis of simian and human HIV-1 integrase interactor INI1/SMARCB1/SNF5.
    Pyeon D; Price L; Park IW
    Arch Virol; 2015 Dec; 160(12):3085-91. PubMed ID: 26350979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of HIV-1 virion production by a transdominant mutant of integrase interactor 1.
    Yung E; Sorin M; Pal A; Craig E; Morozov A; Delattre O; Kappes J; Ott D; Kalpana GV
    Nat Med; 2001 Aug; 7(8):920-6. PubMed ID: 11479624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of early stages of HIV-1 assembly by INI1/hSNF5 transdominant negative mutant S6.
    Cano J; Kalpana GV
    J Virol; 2011 Mar; 85(5):2254-65. PubMed ID: 21159874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of the INI1 tumor suppressor does not impair the expression of multiple BRG1-dependent genes or the assembly of SWI/SNF enzymes.
    Doan DN; Veal TM; Yan Z; Wang W; Jones SN; Imbalzano AN
    Oncogene; 2004 Apr; 23(19):3462-73. PubMed ID: 14990991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complementation analyses suggest species-specific functions of the SNF5 homology domain.
    Bonazzi V; Medjkane S; Quignon F; Delattre O
    Biochem Biophys Res Commun; 2005 Oct; 336(2):634-8. PubMed ID: 16154112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chromatin remodeling factor encoded by ini1 induces G1 arrest and apoptosis in ini1-deficient cells.
    Ae K; Kobayashi N; Sakuma R; Ogata T; Kuroda H; Kawaguchi N; Shinomiya K; Kitamura Y
    Oncogene; 2002 May; 21(20):3112-20. PubMed ID: 12082626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chromatin-remodeling factor INI1/hSNF5/BAF47 is involved in activation of the colony stimulating factor 1 promoter.
    Pan X; Song Z; Zhai L; Li X; Zeng X
    Mol Cells; 2005 Oct; 20(2):183-8. PubMed ID: 16267391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of INI1/hSNF5 in gene regulation and cancer.
    Stojanova A; Penn LZ
    Biochem Cell Biol; 2009 Feb; 87(1):163-77. PubMed ID: 19234532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. hSNF5/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities.
    Bourdeaut F; Fréneaux P; Thuille B; Lellouch-Tubiana A; Nicolas A; Couturier J; Pierron G; Sainte-Rose C; Bergeron C; Bouvier R; Rialland X; Laurence V; Michon J; Sastre-Garau X; Delattre O
    J Pathol; 2007 Feb; 211(3):323-30. PubMed ID: 17152049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. hSNF5/INI1 inactivation is mainly associated with homozygous deletions and mitotic recombinations in rhabdoid tumors.
    Rousseau-Merck MF; Versteege I; Legrand I; Couturier J; Mairal A; Delattre O; Aurias A
    Cancer Res; 1999 Jul; 59(13):3152-6. PubMed ID: 10397258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytoplasmic interaction of the tumour suppressor protein hSNF5 with dynamin-2 controls endocytosis.
    Alfonso-Pérez T; Domínguez-Sánchez MS; García-Domínguez M; Reyes JC
    Oncogene; 2014 Jun; 33(23):3064-74. PubMed ID: 23851497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. INI1/hSNF5/BAF47 represses c-fos transcription via a histone deacetylase-dependent manner.
    Pan X; Zhai L; Sun R; Li X; Zeng X
    Biochem Biophys Res Commun; 2005 Dec; 337(4):1052-8. PubMed ID: 16219292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of Snf5 Induces Formation of an Aberrant SWI/SNF Complex.
    Sen P; Luo J; Hada A; Hailu SG; Dechassa ML; Persinger J; Brahma S; Paul S; Ranish J; Bartholomew B
    Cell Rep; 2017 Feb; 18(9):2135-2147. PubMed ID: 28249160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The tumour suppressor hSNF5/INI1 controls the differentiation potential of malignant rhabdoid cells.
    Albanese P; Belin MF; Delattre O
    Eur J Cancer; 2006 Sep; 42(14):2326-34. PubMed ID: 16908131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.